As seen in the healthy human fibroblast assays, the expression of αSMA and percentage of stimulated cells among fibroblasts from IPF patients were also increased after TGFβ treatment (Fig. 6B). The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.